TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,979
|
13,267
|
16,236 |
Financial expenses |
53
|
27
|
34 |
Earnings before taxes |
563
|
269
|
1,088 |
Total assets |
4,468
|
4,332
|
3,939 |
Current assets |
3,534
|
3,239
|
3,200 |
Current liabilities |
970
|
1,059
|
1,401 |
Equity capital |
2,534
|
2,234
|
2,138 |
- share capital |
89
|
95
|
100 |
Employees (average) |
41
|
38 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.7%
|
51.6%
|
54.3% |
Turnover per employee |
324
|
427 | |
Profit as a percentage of turnover |
4.0%
|
2.0%
|
6.7% |
Return on assets (ROA) |
13.8%
|
6.8%
|
28.5% |
Current ratio |
364.3%
|
305.9%
|
228.4% |
Return on equity (ROE) |
22.2%
|
12.0%
|
50.9% |
Change turnover |
1,555
|
-2,116
|
930 |
Change turnover % |
13%
|
-14%
|
6% |
Chg. No. of employees | 3 | ||
Chg. No. of employees % | 8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.